A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.
Dr. Alice Telesnitsky, professor of microbiology and immunology at the University of Michigan Medical School
A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.
The National Institutes of Health grant, which will be distributed during a five-year period, establishes the Center for HIV RNA Studies, or CRNA.
Alice Telesnitsky, PhD, a professor of microbiology and immunology at the U-M Medical School, will head the CRNA and says the grant brings together researchers in a variety of disciplines to tackle the sometimes tricky HIV-1 RNA molecule, which plays an essential role in a virus ability to reproduce itself.
Viruses are made up of proteins and RNA, and most research focuses on the proteins, she says. Because RNA is a simple molecule, it can sometimes appear nondescript when we look at it. This grant will unite a team of people who will look at RNA on different scales, assessing its structure, movement and replication.
Telesnitsky says a better understanding of RNAs biological processes could ultimately lead to innovative treatments for AIDS and other human diseases.
Researchers from Telesnitskys lab at U-M, as well as scientists from 13 other institutions across the country, will use the NIH grant to take a multidisciplinary approach to the research.
Telesnitsky says the team includes world leaders in fields such as structural biology, chemistry, cell and computation biology, molecular biology and virology.
Funding for the grant comes from the National Institute of General Medical Sciences and the NIHs National Institutes of Allergy and Infectious Diseases.
This is an absolutely outstanding group of structural biologists and virologists focused on an understudied yet critical component of the HIV virionthe genomic RNA, says Michael Sakalian, PhD, the NIGMS official who oversees the grant for the specialized center. Their efforts to elucidate the structural and functional roles of RNA in the viral life cycle will advance our fundamental understanding of host-virus interactions as well as identify potential new targets for therapeutic intervention.
Source: University of Michigan Health System
Â
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.